Patent details

EP2629801 Title: SYNERGISTIC EFFECTS BETWEEN AURISTATIN-BASED ANTIBODY DRUG CONJUGATES AND INHIBITORS OF THE PI3K-AKT MTOR PATHWAY

Basic Information

Publication number:
EP2629801
PCT Application Number:
US2011057130
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP118351584
PCT Publication Number:
WO2012054748
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SYNERGISTIC EFFECTS BETWEEN AURISTATIN-BASED ANTIBODY DRUG CONJUGATES AND INHIBITORS OF THE PI3K-AKT MTOR PATHWAY
French Title of Invention:
EFFETS SYNERGIQUES ENTRE DES CONJUGUÉS D'ANTICORPS ET DE MÉDICAMENT À BASE D'AURISTATINE ET DES INHIBITEURS DE LA VOIE PI3K-AKT-MTOR
German Title of Invention:
SYNERGIEWIRKUNG ZWISCHEN AURISTATIN-BASIERTEN ANTIKÖRPER-WIRKSTOFFKONJUGATEN UND HEMMERN DES PI3K-AKT-MTOR-SIGNALWEGS
SPC Number:

Dates

Filing date:
20/10/2011
Grant date:
15/05/2019
EP Publication Date:
28/08/2013
PCT Publication Date:
26/04/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/05/2019
EP B1 Publication Date:
15/05/2019
EP B2 Publication Date:
EP B3 Publication Date:
27/11/2019
Lapsed date:
20/10/2019
Expiration date:
20/10/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/11/2019
 
 

Name:
Seattle Genetics, Inc.
Address:
21823 30th Drive, S.E., Bothell, WA 98021, United States (US)

Inventor

1

Name:
LEWIS, Timothy S.
Address:
United States (US)

2

Name:
LAW, Che-Leung
Address:
United States (US)

3

Name:
MCEARCHERN, Julie A.
Address:
United States (US)

Priority

1

Priority Number:
405767 P
Priority Date:
22/10/2010
Priority Country:
United States (US)

2

Priority Number:
201161445785 P
Priority Date:
23/02/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4375; A61K 31/46; A61K 45/06; A61P 35/00; A61K 47/68;

Publication

European Patent Bulletin

1

Issue number:
201920
Publication date:
15/05/2019
Description:
Grant (B1)

2

Issue number:
201924
Publication date:
12/06/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
201927
Publication date:
03/07/2019
Description:
Request for limitation Filed (Art.105a)

4

Issue number:
201939
Publication date:
25/09/2019
Description:
Request for limitation of patent allowed

5

Issue number:
201948
Publication date:
27/11/2019
Description:
Limited Patent Specification (B3)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages